TAO Synergies Inc. (TAOX)

NASDAQ: TAOX · Real-Time Price · USD
6.55
+0.07 (1.08%)
At close: May 11, 2026, 4:00 PM EDT
6.50
-0.05 (-0.76%)
Pre-market: May 12, 2026, 7:00 AM EDT
Market Cap48.94M +1,414.6%
Revenue (ttm)299,061
Net Income-29.08M
EPS-8.81
Shares Out 7.47M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume145,322
Open6.43
Previous Close6.48
Day's Range6.05 - 6.90
52-Week Range2.12 - 11.98
Beta1.53
Analystsn/a
Price Targetn/a
Earnings DateMay 14, 2026

About TAOX

TAO Synergies Inc. owns and operates an AI token. It focuses on the pure play artificial intelligence (AI) crypto coin, TAO, the native cryptocurrency of Bittensor and a decentralized blockchain network for machine learning and AI. The company was formerly known as Synaptogenix, Inc. and changed its name to TAO Synergies Inc. in June 2025. TAO Synergies Inc was incorporated in 2012 and is headquartered in New York, New York.

Sector Technology
Founded 2012
Employees 5
Stock Exchange NASDAQ
Ticker Symbol TAOX
Full Company Profile

Financial Performance

Financial Statements

News

Options Trading Now Available on Tradr's BEX, CSEX, NNEX & SNPXcsex

NEW YORK, Nov. 18, 2025 /PRNewswire/ -- Tradr ETFs, a provider of ETFs designed for sophisticated investors and professional traders, today announced that options trading is now available on its four ...

Other symbols: BEXCSEXNNEXSNPX
6 months ago - PRNewsWire

TAO Synergies and Yuma Asset Management to Host Livestream on X: Bittensor (TAO) and DeAI Innovation

November 18 at 12:15 p.m. ET—Bittensor expert James Altucher and Yuma CRO Evan Malanga dive deep into TAO, decentralized AI, and network outlook as TAO halving approaches TAO Synergies is the largest ...

6 months ago - PRNewsWire

Tradr Launches Leveraged ETFs on Bloom Energy, Celestica, NANO Nuclear & Synopsys

First-to-market funds seek to provide 200% long exposure on exciting growth stories NEW YORK , Nov. 13, 2025 /PRNewswire/ -- Tradr ETFs, a provider of ETFs designed for sophisticated investors and pro...

Other symbols: BEXCSEXNNEXSNPX
6 months ago - PRNewsWire

TAO Synergies files to sell 22.3M shares of common stock for holders

The selling stockholders will receive all of the proceeds from any sales of the shares offered.

6 months ago - TheFly

Tradr Set to Debut ETFs Targeting Bloom Energy, Celestica, Nano Nuclear and Synopsys

Four funds represent first-to-market strategies offering 200% exposure on trending growth stocks NEW YORK , Nov. 11, 2025 /PRNewswire/ -- Tradr ETFs, a provider of ETFs designed for sophisticated inve...

Other symbols: BEXCSEXNNEXSNPX
6 months ago - PRNewsWire

TAO Synergies announces initial $750K investment in Bittensor Subnet Funds

TAO Synergies (TAOX) announced an initial $750K investment in Yuma Asset Management’s Bittensor Subnet Funds, enhancing the company’s exposure to subnets in the Bittensor ecosystem. This move builds o...

6 months ago - TheFly

TAO Synergies Announces Initial $750,000 Investment in Yuma Asset Management's Subnet Funds

Seeks to optimize returns for shareholders while fostering evolution of Bittensor's decentralized machine intelligence marketplace NEW YORK , Nov. 4, 2025 /PRNewswire/ -- TAO Synergies Inc. (Nasdaq: T...

6 months ago - PRNewsWire

TAO Synergies reports total TAO increased to 54,058 tokens

TAO Synergies (TAOX) announced that through acquisition and staking, the Company’s total TAO holdings have increased to 54,058 tokens. This further solidifies TAO Synergies’ position as the largest pu...

7 months ago - TheFly

TAO Synergies Raises Bittensor (TAO) Holdings to over 54,000 Tokens, Largest Publicly Traded Holder of Top Decentralized AI Cryptocurrency

NEW YORK , Oct. 20, 2025 /PRNewswire/ -- TAO Synergies Inc. (Nasdaq: TAOX) ("TAO Synergies" or the "Company"), a digital asset treasury company focused on Bittensor (TAO), the premier crypto token for...

7 months ago - PRNewsWire

TAO Synergies announces $11M private placement

TAO Synergies (TAOX) announced that it has entered into a securities purchase agreement with existing investors, James Altucher and a new investor, DCG, for a $11M financing. The financing involves…

7 months ago - TheFly

TAO Synergies Announces $11 Million Private Placement

Financing supported by existing stockholders, TAO Strategy Advisor James Altucher, and new investor DCG NEW YORK , Oct. 13, 2025 /PRNewswire/ -- TAO Synergies Inc. (Nasdaq: TAOX) (the "Company"), a di...

7 months ago - PRNewsWire

TAO Synergies Launches "The TAO Daily," the Premier Media Platform for All Things Bittensor (TAO)

New digital hub to educate, engage, and connect the growing TAO community and decentralized AI contributors NEW YORK , Sept. 22, 2025 /PRNewswire/ -- TAO Synergies Inc. (Nasdaq: TAOX) (the "Company"),...

8 months ago - PRNewsWire

TAO Synergies Digital Assets Advisor James Altucher Speaks at Google's Planet Scale Consumer AI Event

Remarks focused on rapid growth of decentralized AI, top catalysts for Bittensor's ecosystem and TAO Synergies NEW YORK , Sept. 8, 2025 /PRNewswire/ -- TAO Synergies Inc. (Nasdaq: TAOX) (the "Company"...

8 months ago - PRNewsWire

TAO Synergies Welcomes Top Bittensor (TAO) Leader as Advisor for AI-Focused Crypto Treasury Strategy

Joseph Jacks to support Company's TAO pure-play treasury initiatives TAO treasury strategy anchored at intersection of decentralized AI and cryptocurrencies NEW YORK , Aug. 26, 2025 /PRNewswire/ -- TA...

9 months ago - PRNewsWire

TAO Synergies files $100M mixed securities shelf

16:52 EDT TAO Synergies (TAOX) files $100M mixed securities shelf

9 months ago - TheFly

TAO Synergies acquires $10M of Bittensor

TAO Synergies (TAOX) announced that as of July 17, it has acquired 29,899 Bittensor, or TAO, tokens, for a total purchase price of $10.0M, at an average price of approximately…

10 months ago - TheFly

TAO Synergies files to sell 5.04M shares of common stock for holders

17:04 EDT TAO Synergies (TAOX) files to sell 5.04M shares of common stock for holders

10 months ago - TheFly

TAO Synergies (Formerly Synaptogenix) Begins Trading Under New Nasdaq Stock Symbol "TAOX" Effective at Market Open Today

New name and stock symbol highlight strategic commitment to TAO, the leading AI cryptocurrency NEW YORK , July 1, 2025 /PRNewswire/ -- TAO Synergies Inc. (Nasdaq: TAOX) (the "Company"), formerly Synap...

11 months ago - PRNewsWire

Synaptogenix Announces Name Change to TAO Synergies and New Ticker Symbol "TAOX" for Alignment with AI-Focused Crypto Treasury Strategy

New trading symbol "TAOX" effective Tuesday, July 1, 2025, New name represents Company's strategic focus on the synergies between cryptocurrency and AI NEW YORK , June 26, 2025 /PRNewswire/ -- TAO Syn...

11 months ago - PRNewsWire

Synaptogenix Announces Initial TAO Acquisition under Crypto Treasury Strategy, Appoints BitGo as Custodian, and Commences Yield Generation Through Staking

Strategic capital deployment into TAO advances Synaptogenix's blockchain treasury model, leveraging BitGo's custody, trading and staking capabilities to generate token-based yield NEW YORK , June 24, ...

11 months ago - PRNewsWire

Synaptogenix Appoints Crypto Expert to Lead Digital Asset Treasury Strategy Focused Exclusively on Top-Valued AI Token

Singular focus on Bittensor (TAO), the leading AI token by adoption and market capitalization James Altucher to lead TAO token strategy initiatives Planned initial acquisition of $10 million in TAO eq...

1 year ago - PRNewsWire

Synaptogenix Board of Directors Forms Special Committee to Explore Value Creation Opportunities Utilizing Balance Sheet Strength

$19.6 million in cash and cash equivalents as of September 30, 2024 Dramatically reduced cash burn rate expected NEW YORK , Dec. 20, 2024 /PRNewswire/ -- Synaptogenix, Inc. (Nasdaq: SNPX) ("Synaptogen...

1 year ago - PRNewsWire

Synaptogenix Announces $5.0 Million Financing

NEW YORK , Sept. 11, 2024 /PRNewswire/ -- Synaptogenix, Inc. (Nasdaq: SNPX) ("Synaptogenix" or the "Company"), an emerging biopharmaceutical company developing therapeutics for neurodegenerative disor...

1 year ago - PRNewsWire

Synaptogenix Announces New Collaboration with LSU Health New Orleans for Study of Proprietary Analogs in Spinal Cord Injury

Company holds exclusive rights to family of polyunsaturated fatty acid (PUFA) analogs New patent covers proprietary analogs in the treatment of neurodegenerative diseases NEW YORK , July 18, 2024 /PRN...

1 year ago - PRNewsWire

Synaptogenix Announces FDA Authorization of IND Application for Clinical Trial for Bryostatin-1 in Multiple Sclerosis

Collaborative study will evaluate drug's potential to improve synaptic health and cognitive function in MS patients NEW YORK , June 26, 2024 /PRNewswire/ -- Synaptogenix, Inc. (Nasdaq: SNPX) ("Synapto...

2 years ago - PRNewsWire